Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10108975 Medical accountable provider platform

Patent 10108975 was granted and assigned to RxAnte on October, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
RxAnte
RxAnte
0
Date Filed
June 30, 2014
0
Date of Patent
October 23, 2018
0
Patent Applicant
RxAnte
RxAnte
0
Patent Application Number
14319450
0
Patent Citations Received
‌
US Patent 12124973 Model-based patient adherence classification and intervention
0
‌
US Patent 10528702 Multi-modal communication with patients based on historical analysis
‌
US Patent 10558785 Variable list based caching of patient information for evaluation of patient rules
‌
US Patent 10565309 Interpreting the meaning of clinical values in electronic medical records
‌
US Patent 10685089 Modifying patient communications based on simulation of vendor communications
‌
US Patent 10923231 Dynamic selection and sequencing of healthcare assessments for patients
‌
US Patent 10937526 Cognitive evaluation of assessment questions and answers to determine patient characteristics
‌
US Patent 11037682 Dynamic selection and sequencing of healthcare assessments for patients
‌
US Patent 11037658 Clinical condition based cohort identification and evaluation
‌
US Patent 11315685 Method and system for predicting optimal epilepsy treatment regimes
•••
Patent Inventor Names
Daniel Smith
0
Morgan Beschle
0
Spencer Cherry
0
Aaron McKethan
0
Joshua S. Benner
0
Kimball Lewis
0
Loren Lidsky
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10108975
0
Patent Primary Examiner
‌
Joy Chng
0

Find more entities like US Patent 10108975 Medical accountable provider platform

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.